Abstract
The lifetime risk of overt hypothyroidism is around 5%, and this disease is usually preceded by subclinical hypothyroidism, which has an even higher prevalence (estimated to be up to 9%). Hypothyroidism has been linked with cardiac dysfunction, atherosclerosis, hypertension and coagulopathy. Intuitively, this increased morbidity is expected to shorten patients' lifespan, but definitive data are lacking on whether either of these hypothyroid states (particularly overt hypothyroidism) increase mortality. Study findings are inconsistent and, overall, the pooled data do not demonstrate increased mortality in patients with either subclinical or overt hypothyroidism. However, none of the available studies was adequately designed to answer this question. This Review discusses major shortcomings in those studies, such as population dissimilarities, hypothyroid state classification and misclassification, the inclusion of nonthyroidal illness, drug interference from concurrent therapies, serious comorbidities (for example, cardiovascular disease), differences in duration of follow-up and the number of levothyroxine-treated individuals. Taken together, the data exhibit little evidence of systematic bias and no strong scientific proof of increased mortality related to either subclinical or overt hypothyroidism. Future studies, however, should take the above-mentioned shortcomings and potential genetic confounding into consideration.
Key Points
-
Hypothyroidism is associated with increased morbidity, such as hypertension and coronary heart disease
-
Published data do not unequivocally support an increased risk of mortality in individuals with either subclinical or overt hypothyroidism
-
Interpretation of the study results relating to this association is complicated by considerable variation in their methodology
-
Previous studies were not designed to determine whether subclinical or overt hypothyroidism increase mortality risk; one important confounding factor is that many patients are treated with levothyroxine
-
Future research should include adequately powered, long-term follow-up studies of cohorts with clearly defined diagnoses of thyroid diseases and account for genetic and environmental confounding variables
This is a preview of subscription content, access via your institution
Access options
Subscribe to this journal
Receive 12 print issues and online access
$209.00 per year
only $17.42 per issue
Rent or buy this article
Prices vary by article type
from$1.95
to$39.95
Prices may be subject to local taxes which are calculated during checkout
Similar content being viewed by others
References
Carle, A. et al. Epidemiology of subtypes of hypothyroidism in Denmark. Eur. J. Endocrinol. 154, 21–28 (2006).
Vanderpump, M. P. et al. The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey. Clin. Endocrinol. (Oxf.) 43, 55–68 (1995).
Canaris, G. J., Manowitz, N. R., Mayor, G. & Ridgway, E. C. The Colorado thyroid disease prevalence study. Arch. Intern. Med. 160, 526–534 (2000).
Brix, T. H., Kyvik, K. O. & Hegedüs, L. A population-based study of chronic autoimmune hypothyroidism in Danish twins. J. Clin. Endocrinol. Metab. 85, 536–539 (2000).
Laurberg, P. et al. Iodine intake as a determinant of thyroid disorders in populations. Best Pract. Res. Clin. Endocrinol. Metab. 24, 13–27 (2010).
Jensen, E. et al. Establishment of a serum thyroid stimulating hormone (TSH) reference interval in healthy adults. The importance of environmental factors, including thyroid antibodies. Clin. Chem. Lab. Med. 42, 824–832 (2004).
Erem, C. Thyroid disorders and hypercoagulability. Semin. Thromb. Hemost. 37, 17–26 (2011).
Pearce, E. N. Hypothyroidism and dyslipidemia: modern concepts and approaches. Curr. Cardiol. Rep. 6, 451–456 (2004).
Goldman, M. B., Monson, R. R. & Maloof, F. Cancer mortality in women with thyroid disease. Cancer Res. 50, 2283–2289 (1990).
Maldonado, L. S., Murata, G. H., Hershman, J. M. & Braunstein, G. D. Do thyroid function tests independently predict survival in the critically ill? Thyroid 2, 119–123 (1992).
Imaizumi, M. et al. Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 89, 3365–3370 (2004).
Sgarbi, J. A., Matsumura, L. K., Kasamatsu, T. S., Ferreira, S. R. & Maciel, R. M. Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study. Eur. J. Endocrinol. 162, 569–577 (2010).
McQuade, C. et al. Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: A PreCIS database study. Thyroid 21, 837–843 (2011).
Flynn, R. W., MacDonald, T. M., Jung, R. T., Morris, A. D. & Leese, G. P. Mortality and vascular outcomes in patients treated for thyroid dysfunction. J. Clin. Endocrinol. Metab. 91, 2159–2164 (2006).
Nyirenda, M. J. et al. Thyroid disease and increased cardiovascular risk. Thyroid 15, 718–724 (2005).
Boekholdt, S. M. et al. Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study. Clin. Endocrinol. (Oxf.) 72, 404–410 (2010).
Razvi, S., Weaver, J. U., Vanderpump, M. P. & Pearce, S. H. The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort. J. Clin. Endocrinol. Metab. 95, 1734–1740 (2010).
Rodondi, N. et al. Subclinical hypothyroidism and the risk of heart failure, other cardiovascular events, and death. Arch. Intern. Med. 165, 2460–2466 (2005).
Haentjens, P., van Meerhaeghe, A., Poppe, K. & Velkeniers, B. Subclinical thyroid dysfunction and mortality: an estimate of relative and absolute excess all-cause mortality based on time-to-event data from cohort studies. Eur. J. Endocrinol. 159, 329–341 (2008).
Rodondi, N. et al. Subclinical hypothyroidism and the risk of coronary heart disease and mortality. JAMA 304, 1365–1374 (2010).
Singh, S. et al. Impact of subclinical thyroid disorders on coronary heart disease, cardiovascular and all-cause mortality: a meta-analysis. Int. J. Cardiol. 125, 41–48 (2008).
Ochs, N. et al. Meta-analysis: subclinical thyroid dysfunction and the risk for coronary heart disease and mortality. Ann. Intern. Med. 148, 832–845 (2008).
Völzke, H., Schwahn, C., Wallaschofski, H. & Dörr, M. Review: The association of thyroid dysfunction with all-cause and circulatory mortality: is there a causal relationship? J. Clin. Endocrinol. Metab. 92, 2421–2429 (2007).
Buffenstein, R. & Pinto, M. Endocrine function in naturally long-living small mammals. Mol. Cell Endocrinol. 299, 101–111 (2009).
Atzmon, G., Barzilai, N., Hollowell, J. G., Surks, M. I. & Gabriely, I. Extreme longevity is associated with increased serum thyrotropin. J. Clin. Endocrinol. Metab. 94, 1251–1254 (2009).
Parle, J. V., Maisonneuve, P., Sheppard, M. C., Boyle, P. & Franklyn, J. A. Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study. Lancet 358, 861–865 (2001).
Gussekloo, J. et al. Thyroid status, disability and cognitive function, and survival in old age. JAMA 292, 2591–2599 (2004).
Walsh, J. P. et al. Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch. Intern. Med. 165, 2467–2472 (2005).
Cappola, A. R. et al. Thyroid status, cardiovascular risk, and mortality in older adults. JAMA 295, 1033–1041 (2006).
Iervasi, G. et al. Association between increased mortality and mild thyroid dysfunction in cardiac patients. Arch. Intern. Med. 167, 1526–1532 (2007).
Asvold, B. O., Bjøro, T., Nilsen, T. I., Gunnell, D. & Vatten, L. J. Thyrotropin levels and risk of fatal coronary heart disease: the HUNT study. Arch. Intern. Med. 168, 855–860 (2008).
Radácsi, A. et al. Mortality rate of chronically ill geriatric patients with subnormal serum thyrotropin concentration: a 2-yr follow-up study. Endocrine 21, 133–136 (2003).
Bauer, D. C., Rodondi, N., Stone, K. L. & Hillier, T. A. Thyroid hormone use, hyperthyroidism and mortality in older women. Am. J. Med. 120, 343–349 (2007).
Chubb, S. A., Davis, W. A., Inman, Z. & Davis, T. M. Prevalence and progression of subclinical hypothyroidism in women with type 2 diabetes: the Fremantle Diabetes Study. Clin. Endocrinol. (Oxf.) 62, 480–486 (2005).
Schultz, M. et al. Cardiovascular events in thyroid disease: a population based, prospective study. Horm. Metab Res. 43, 653–659 (2011).
de Jongh, R. T. et al. Endogenous subclinical thyroid disorders, physical and cognitive function, depression, and mortality in older individuals. Eur. J. Endocrinol. 165, 545–554 (2011).
Petersen, K., Bengtsson, C., Lapidus, L., Lindstedt, G. & Nystrom, E. Morbidity, mortality, and quality of life for patients treated with levothyroxine. Arch. Intern. Med. 150, 2077–2081 (1990).
Alevizaki, M., Synetou, M., Xynos, K., Alevizaki, C. C. & Vemmos, K. N. Hypothyroidism as a protective factor in acute stroke patients. Clin. Endocrinol. (Oxf.) 65, 369–372 (2006).
Vanderpump, M. P. et al. The development of ischemic heart disease in relation to autoimmune thyroid disease in a 20-year follow-up study of an English community. Thyroid 6, 155–160 (1996).
Slag, M. F. et al. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 245, 43–45 (1981).
Iglesias, P. et al. Alterations in thyroid function tests in aged hospitalized patients: prevalence, aetiology and clinical outcome. Clin. Endocrinol. (Oxf.) 70, 961–967 (2009).
Franklyn, J. A. Thyroid disease and its treatment: short- and long-term consequences. J. R. Coll. Physicians Lond. 33, 564–567 (1999).
Osman, F., Gammage, M. D. & Franklyn, J. A. Thyroid disease and its treatment: short-term and long-term cardiovascular consequences. Curr. Opin. Pharmacol. 1, 626–631 (2001).
van den Beld, A. W., Visser, T. J., Feelders, R. A., Grobbee, D. E. & Lamberts, S. W. Thyroid hormone concentrations, disease, physical function, and mortality in elderly men. J. Clin. Endocrinol. Metab. 90, 6403–6409 (2005).
Lloyd-Jones, D. et al. Heart disease and stroke statistics--2010 update: a report from the American Heart Association. Circulation 121, 948–954 (2010).
Klein, I. & Ojamaa, K. Thyroid hormone and the cardiovascular system. N. Engl. J. Med. 344, 501–509 (2001).
Biondi, B. & Cooper, D. S. The clinical significance of subclinical thyroid dysfunction. Endocr. Rev. 29, 76–131 (2008).
Biondi, B. & Klein, I. Hypothyroidism as a risk factor for cardiovascular disease. Endocrine 24, 1–13 (2004).
Kahaly, G. J. & Dillmann, W. H. Thyroid hormone action in the heart. Endocr. Rev. 26, 704–728 (2005).
Kahaly, G. J. Cardiovascular and atherogenic aspects of subclinical hypothyroidism. Thyroid 10, 665–679 (2000).
Luboshitzky, R., Aviv, A., Herer, P. & Lavie, L. Risk factors for cardiovascular disease in women with subclinical hypothyroidism. Thyroid 12, 421–425 (2002).
Nagasaki, T. et al. Increased pulse wave velocity in subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 91, 154–158 (2006).
Biondi, B. et al. Left ventricular diastolic dysfunction in patients with subclinical hypothyroidism. J. Clin. Endocrinol. Metab. 84, 2064–2067 (1999).
Vitale, G. et al. Left ventricular myocardial impairment in subclinical hypothyroidism assessed by a new ultrasound tool: pulsed tissue Doppler. J. Clin. Endocrinol. Metab. 87, 4350–4355 (2002).
Lekakis, J. et al. Flow-mediated, endothelium-dependent vasodilation is impaired in subjects with hypothyroidism, borderline hypothyroidism, and high-normal serum thyrotropin (TSH) values. Thyroid 7, 411–414 (1997).
Vescovi, P. P. et al. The spectrum of coagulation abnormalities in thyroid disorders. Semin. Thromb. Hemost. 37, 7–10 (2011).
Cappola, A. R. & Ladenson, P. W. Hypothyroidism and atherosclerosis. J. Clin. Endocrinol. Metab. 88, 2438–2444 (2003).
Lindeman, R. D. et al. Subclinical hypothyroidism in a biethnic, urban community. J. Am. Geriatr. Soc. 47, 703–709 (1999).
Holm, L. E., Blomgren, H. & Lowhagen, T. Cancer risks in patients with chronic lymphocytic thyroiditis. N. Engl. J. Med. 312, 601–604 (1985).
Acton, R. T., Go, R. C. & Roseman, J. M. Genetics and cardiovascular disease. Ethn. Dis. 14, S2–8–16 (2004).
Bak, S., Gaist, D., Sindrup, S. H., Skytthe, A. & Christensen, K. Genetic liability in stroke: a long-term follow-up study of Danish twins. Stroke 33, 769–774 (2002).
Herskind, A. M. et al. The heritability of human longevity: a population-based study of 2872 Danish twin pairs born 1870–1900. Hum. Genet. 97, 319–323 (1996).
Rice, F., Harold, G. T. & Thapar, A. Assessing the effects of age, sex and shared environment on the genetic aetiology of depression in childhood and adolescence. J. Child Psychol. Psychiatry 43, 1039–1051 (2002).
Madden, P. A., Pedersen, N. L., Kaprio, J., Koskenvuo, M. J. & Martin, N. G. The epidemiology and genetics of smoking initiation and persistence: crosscultural comparisons of twin study results. Twin Res. 7, 82–97 (2004).
Umpierrez, G. E. et al. Thyroid dysfunction in patients with type 1 diabetes: a longitudinal study. Diabetes Care 26, 1181–1185 (2003).
Gulseren, S. et al. Depression, anxiety, health-related quality of life, and disability in patients with overt and subclinical thyroid dysfunction. Arch. Med. Res. 37, 133–139 (2006).
Guimarães, J. M., de Souza, L. C., Baima, J. & Sichieri, R. Depression symptoms and hypothyroidism in a population-based study of middle-aged Brazilian women. J. Affect. Disord. 117, 120–123 (2009).
Laursen, T. M., Munk-Olsen, T. & Gasse, C. Chronic somatic comorbidity and excess mortality due to natural causes in persons with schizophrenia or bipolar affective disorder. PLoS ONE 6, e24597 (2011).
Bauer, M., Heinz, A. & Whybrow, P. C. Thyroid hormones, serotonin and mood: of synergy and significance in the adult brain. Mol. Psychiatry 7, 140–156 (2002).
Brix, T. H., Hansen, P. S., Kyvik, K. O. & Hegedüs, L. Cigarette smoking and risk of clinically overt thyroid disease: a population-based twin case–control study. Arch. Intern. Med. 160, 661–666 (2000).
Belin, R. M., Astor, B. C., Powe, N. R. & Ladenson, P. W. Smoke exposure is associated with a lower prevalence of serum thyroid autoantibodies and thyrotropin concentration elevation and a higher prevalence of mild thyrotropin concentration suppression in the third National Health and Nutrition Examination Survey (NHANES III). J. Clin. Endocrinol. Metab. 89, 6077–6086 (2004).
Davidsen, M., Kjoller, M. & Helweg-Larsen, K. The Danish National Cohort Study (DANCOS). Scand. J. Public Health 39, 131–135 (2011).
Madsen, M., Andersen, A. M., Christensen, K., Andersen, P. K. & Osler, M. Does educational status impact adult mortality in Denmark? A twin approach. Am. J. Epidemiol. 172, 225–234 (2010).
Andersen, K. K. & Olsen, T. S. Reduced poststroke mortality in patients with stroke and atrial fibrillation treated with anticoagulants: results from a Danish quality-control registry of 22,179 patients with ischemic stroke. Stroke 38, 259–263 (2007).
Woloshin, S., Schwartz, L. M. & Welch, H. G. The risk of death by age, sex, and smoking status in the United States: putting health risks in context. J. Natl Cancer Inst. 100, 845–853 (2008).
Hansen, P. S., Brix, T. H., Sorensen, T. I., Kyvik, K. O. & Hegedüs, L. Major genetic influence on the regulation of the pituitary-thyroid axis: a study of healthy Danish twins. J. Clin. Endocrinol. Metab. 89, 1181–1187 (2004).
Brabant, G. et al. Physiological regulation of circadian and pulsatile thyrotropin secretion in normal man and woman. J. Clin. Endocrinol. Metab. 70, 403–409 (1990).
Andersen, S., Pedersen, K. M., Bruun, N. H. & Laurberg, P. Narrow individual variations in serum T4 and T3 in normal subjects: a clue to the understanding of subclinical thyroid disease. J. Clin. Endocrinol. Metab. 87, 1068–1072 (2002).
Karmisholt, J., Andersen, S. & Laurberg, P. Variation in thyroid function in subclinical hypothyroidism: importance of clinical follow-up and therapy. Eur. J. Endocrinol. 164, 317–323 (2011).
Karmisholt, J., Andersen, S. & Laurberg, P. Variation in thyroid function tests in patients with stable untreated subclinical hypothyroidism. Thyroid 18, 303–308 (2008).
Metso, S., Auvinen, A., Salmi, J., Huhtala, H. & Jaatinen, P. Increased long-term cardiovascular morbidity among patients treated with radioactive iodine for hyperthyroidism. Clin Endocrinol (Oxf.) 68, 450–457 (2008).
Warner, M. H. & Beckett, G. J. Mechanisms behind the non-thyroidal illness syndrome: an update. J. Endocrinol. 205, 1–13 (2010).
Hamblin, P. S. et al. Relationship between thyrotropin and thyroxine changes during recovery from severe hypothyroxinemia of critical illness. J. Clin. Endocrinol. Metab. 62, 717–722 (1986).
Karadag, F., Ozcan, H., Karul, A. B., Yilmaz, M. & Cildag, O. Correlates of non-thyroidal illness syndrome in chronic obstructive pulmonary disease. Respir. Med. 101, 1439–1446 (2007).
Haugen, B. R. Drugs that suppress TSH or cause central hypothyroidism. Best Pract. Res. Clin. Endocrinol. Metab. 23, 793–800 (2009).
Eskes, S. A. & Wiersinga, W. M. Amiodarone and thyroid. Best Pract. Res. Clin. Endocrinol. Metab. 23, 735–751 (2009).
Stockigt, J. R. & Lim, C. F. Medications that distort in vitro tests of thyroid function, with particular reference to estimates of serum free thyroxine. Best Pract. Res. Clin. Endocrinol. Metab. 23, 753–767 (2009).
Barbesino, G. Drugs affecting thyroid function. Thyroid 20, 763–770 (2010).
Charlson, M. E., Pompei, P., Ales, K. L. & MacKenzie, C. R. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J. Chronic. Dis. 40, 373–383 (1987).
Toft, A. D. Thyroxine therapy. N. Engl. J. Med. 331, 174–180 (1994).
McGue, M., Osler, M. & Christensen, K. Causal inference and observational research: the utility of twins. Perspect. Psychol. Sci. 5, 546–556 (2010).
DerSimonian, R. & Laird, N. Meta-analysis in clinical trials. Control Clin. Trials 7, 177–188 (1986).
Higgins, J., Thompson, S., Deeks, J. & Altman, D. Statistical heterogeneity in systematic reviews of clinical trials: a critical appraisal of guidelines and practice. J. Health Serv. Res. Policy 7, 51–61 (2002).
Acknowledgements
The authors' research was supported by unrestricted research grants from the Novo Nordisk Foundation. However, this manuscript was not supported by any specific funding.
Author information
Authors and Affiliations
Contributions
All authors contributed equally to researching data for the article, writing the paper, discussions of the content, and review or editing of the manuscript before submission.
Corresponding author
Ethics declarations
Competing interests
The authors declare no competing financial interests.
Rights and permissions
About this article
Cite this article
Thvilum, M., Brandt, F., Brix, T. et al. A review of the evidence for and against increased mortality in hypothyroidism. Nat Rev Endocrinol 8, 417–424 (2012). https://doi.org/10.1038/nrendo.2012.29
Published:
Issue Date:
DOI: https://doi.org/10.1038/nrendo.2012.29
This article is cited by
-
Prognostic role of hypothyroidism and low free-triiodothyronine levels in patients hospitalized with acute heart failure
Internal and Emergency Medicine (2021)
-
Screening delle tireopatie gestazionali, trattamento dell’ipotiroidismo subclinico o dell’ipotiroxinemia in gravidanza. Siamo ancora in cerca di risposte?
L'Endocrinologo (2018)
-
Mortality in persons with undetected and diagnosed hypertension, type 2 diabetes, and hypothyroidism, compared with persons without corresponding disease - a prospective cohort study; The HUNT Study, Norway
BMC Family Practice (2017)
-
Pre-admission TSH levels predict long-term mortality in adults treated for hypothyroidism
Endocrine (2017)
-
The chronic autoimmune thyroiditis quality of life selenium trial (CATALYST): study protocol for a randomized controlled trial
Trials (2014)